Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Influence of Disease Duration on Circulating Levels of miRNAs in Children and Adolescents with New Onset Type 1 Diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Functional Interplay between RNA Viruses and Non-Coding RNA in Mammals

    Research output: Contribution to journalReviewResearchpeer-review

  2. Cell type-selective expression of circular RNAs in human pancreatic islets

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The Rac2 GTPase contributes to cathepsin H-mediated protection against cytokine-induced apoptosis in insulin-secreting cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Characterization of plasma lipidomics in adolescent subjects with increased risk for type 1 diabetes in the DiPiS cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Long Noncoding RNAs in Diabetes and β-Cell Regulation

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  4. Systemic TNFα correlates with residual β-cell function in children and adolescents newly diagnosed with type 1 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Circulating Inflammatory Markers Are Inversely Associated with Heart Rate Variability Measures in Type 1 Diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Circulating microRNAs (miRNAs) have been implicated in several pathologies including type 1 diabetes. In the present study, we aimed to identify circulating miRNAs affected by disease duration in children with recent onset type 1 diabetes. Forty children and adolescents from the Danish Remission Phase Cohort were followed with blood samples drawn at 1, 3, 6, 12, and 60 months after diagnosis. Pancreatic autoantibodies were measured at each visit. Cytokines were measured only the first year. miRNA expression profiling was performed by RT-qPCR. The effect of disease duration was analyzed by mixed models for repeated measurements adjusted for sex and age. Eight miRNAs (hsa-miR-10b-5p, hsa-miR-17-5p, hsa-miR-30e-5p, hsa-miR-93-5p, hsa-miR-99a-5p, hsa-miR-125b-5p, hsa-miR-423-3p, and hsa-miR-497-5p) were found to significantly change in expression (adjusted p-value < 0.05) with disease progression. Three pancreatic autoantibodies, ICA, IA-2A, and GAD65A, and four cytokines, IL-4, IL-10, IL-21, and IL-22, were associated with the miRNAs at different time points. Pathway analysis revealed associations with various immune-mediated signaling pathways. Eight miRNAs that were involved in immunological pathways changed expression levels during the first five years after diagnosis and were associated with variations in cytokine and pancreatic antibodies, suggesting a possible effect on the immunological processes in the early phase of the disease.

Original languageEnglish
JournalNon-Coding RNA
Volume4
Issue number4
Pages (from-to)35
Number of pages11
ISSN2311-553X
DOIs
Publication statusPublished - 21 Nov 2018

ID: 56417217